Ming Yan, Ph.D.

Ming Yan, Ph.D.

Chief Technology OfficeratCytek Biosciences· In proxies 2021–2025

Pay in FY2025-21% from the year before · Cytek Biosciences stock -22.2% the same year

Ming Yan, Ph.D. was paid $1.5M in FY2025 (Dec), down 21%. Cytek Biosciences stock fell 22.2% that year.

Pay$100 in the stock at the end of FY21 → $35
Pay is from the Summary Compensation Table of each Cytek Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cytek BiosciencesPublic company · 5 yr
    • Chief Technology Officer2021 – Present · 5 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?